current user: public

If you have questions about the server, please let us know.

Query: [R] COG5307 SEC7 domain proteins, from VFDB

Results of FFAS03 search in VFDB
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .  630    .  640    .  650    .  660    .  670    .  680    .  690    .  700    .  710    .  720    .  730    .  740    .  750    .  760    .  770    .  780    .  790    .  800    .  810    .  820    .  830    .  840    .  850    .  860    .  870    .  880    .  890    .  900    .  910    .  920    .  930    .  940    .  950    .  960    .  970    .  980    .  990    . 1000    . 1010    . 1020    . 1030    . 1040    . 1050    . 1060    . 1070    . 1080    . 1090    . 1100    . 1110    . 1120    . 1130    . 1140    . 1150    . 1160    . 1170    . 1180    . 1190    . 1200    . 1210    . 1220    . 1230    . 1240    . 1250    . 1260    . 1270    . 1280    . 1290    . 1300    . 1310    . 1320    . 1330    . 1340    . 1350    . 1360    . 1370    . 1380    . 1390    . 1400    . 1410    . 1420    . 1430    . 1440    . 1450    . 1460    . 1470    . 1480    . 1490    . 1500    . 1510    . 1520    . 1530    . 1540    . 1550    . 1560    . 1570    . 1580    . 1590    . 1600    . 1610    . 1620    . 1630    . 1640    . 1650    . 1660    . 1670    . 1680    . 1690    . 1700    . 1710    . 1720    . 1730    . 1740    . 1750    . 1760    . 1770    . 1780    . 1790    . 1800    . 1810    . 1820
# Score Template Links and tools%idFirst MQDASEPVINMPALPMNSVNEQHDRHEDLPEVGTTSVTKIINDSDNEDDENGMDLGRVASESLEGDAVVSIDINTEDSSLSPAKQENEKSPEGIEQKYQEEDLKDDKKSNETIATPVPDAASRASLEKQKSGLTNLEKSTHVVLIKCIEQLIQIKVCMKNEKMKNLMEQLKPLLQTECQFDKFLIVELFQYCFESSQDEVMNISLDTISKLASFAYFSSKDKTPASFGPPKSLLQCMVDMVCDSINDEVVDGNLQLNVVKALSAFILCSEQDSMLHGAILLNSVRKLFNVFLLGDSDTIQSVAQASLTQAVTVVYERLRASHTQSNSTSALPEEDASVTENWVHDEDEPDKKITLHSMASAGTSSLDHVKVDADDPAVTSVENSSIQDAFLVFRSMCRLAVRQTSPDKVSNIRSQAMRAKLISLHLIYRILEKNSDLFMDPTLQFRGIPALKGMTLVHASRQYICLVLSRNAVSPVPQVFEVCCDIFYLMVFSLRAHFKQEIEVFFREVYFPMLDLKNTSYNQKLHTLLIIQRICLNPRALVELYINYDCDRSSTTNVFEQLLFSISKVTTNGPSETISEDIEEILPSLESSERSSTPFLNTNSASLKSEVVQLTTFSDFQLKLKTLQCVLDILQSLSNWAESGLYLSRRGVSTDEQGFVGDYDALSRSDTPVTNPYYNGKQSFEANSHSSSSIALADPSQFESNKQRKKLLRTCINKFNYKPTRGLKMLSENEYVDINDPKAIAEFLFRADGIDKTTLGDYLGEGDEKSISVMHEFIDCLSFINLKFVDALRRLLQCFRLPGEAQKIDRIMLKFSERYMKENPSAFANADTAYILAYSIILLNTDLHSPRIKNKMTKEDFIKNNRGINDGADLDEDYLGFVYDDILKNEIAMKDDQELAAIAPLMNNFSTSSGFTTFTSNGRDLQRVACIQASEEMANKATSVLKKLLYQQKHGSQKTNVYYNATHFEHIGPMLEATWMPILAALSNPLQNSDYVNELNMCLDGFQLVVRIACLFDLDLIRDAFIKTLTNFTNLHSTSEIKLRNTMVIKTLLRIASTEGNNLKDSWKDILTIISQLERVQLIGVGVDETEVPDVINARVRRKNVNIGSSNSIRHVSGSTSRSTRTRSLSKPLSPEAVSELMSTEVVLSIDRIFTQTSSLSGSAIVSFFKALCEVSWDEITSSSDLEQPRLYSLQKLVEISYYNMQRIRVEWSSIWNVLGRFFNMVGSDENRHVAVFALDSLRQLSMHFLEIEELSLFSFQKEFLKPFEYVMASDTVVEVKELVLQCVKQMIQAKISKIKSGWKTLFGVFTFAAKARSEILISMTFDTLVNLFSEHYDTLMQQNCLIDMLISFTELCKNGTNQKISLQSLEIIREVYSSLSTMIKEGLSSKPSVNETFSKYVFPVLFAYYDIIMSAEDLEVRSRALQNLFYIFLEESDDFTEETWEVVSRKFIFPIFSIFGPEADEATVMLRDEEIRTWQSTTLVEALRSLVTLLTRRFDKLHNLLKGYLWLFSNCICRDNITLSRIGTNCMQQLLSGNAYRFEVKDWNLVADMFIELFKETTPHQLLLLETFSNGQGAPVYSENENTQLSHKRGGSLPETSRSISTSSISPEKQMEFRSMIRKCILQLLLISIVAELLDNEEVFNHIPHEHVLKITVAIYDSWQFARKFNEDKSLRITLLNVGFMKQLPNLLRQETASALLYITLLFRLLKTRDPLGKTETDQKIHKLLFPVCAEMLDMYASLVVEKHTRNHAAWQPVIATILDSILNLPLELFSENIHTLYFSCCSMIAKENLDDQLRELLKNYFNRVGHILLNLNAQQELast
1 -321.000[R] COG5307 SEC7 domain proteins  ali  100  1MQDASEPVINMPALPMNSVNEQHDRHEDLPEVGTTSVTKIINDSDNEDDENGMDLGRVASESLEGDAVVSIDINTEDSSLSPAKQENEKSPEGIEQKYQEEDLKDDKKSNETIATPVPDAASRASLEKQKSGLTNLEKSTHVVLIKCIEQLIQIKVCMKNEKMKNLMEQLKPLLQTECQFDKFLIVELFQYCFESSQDEVMNISLDTISKLASFAYFSSKDKTPASFGPPKSLLQCMVDMVCDSINDEVVDGNLQLNVVKALSAFILCSEQDSMLHGAILLNSVRKLFNVFLLGDSDTIQSVAQASLTQAVTVVYERLRASHTQSNSTSALPEEDASVTENWVHDEDEPDKKITLHSMASAGTSSLDHVKVDADDPAVTSVENSSIQDAFLVFRSMCRLAVRQTSPDKVSNIRSQAMRAKLISLHLIYRILEKNSDLFMDPTLQFRGIPALKGMTLVHASRQYICLVLSRNAVSPVPQVFEVCCDIFYLMVFSLRAHFKQEIEVFFREVYFPMLDLKNTSYNQKLHTLLIIQRICLNPRALVELYINYDCDRSSTTNVFEQLLFSISKVTTNGPSETISEDIEEILPSLESSERSSTPFLNTNSASLKSEVVQLTTFSDFQLKLKTLQCVLDILQSLSNWAESGLYLSRRGVSTDEQGFVGDYDALSRSDTPVTNPYYNGKQSFEANSHSSSSIALADPSQFESNKQRKKLLRTCINKFNYKPTRGLKMLSENEYVDINDPKAIAEFLFRADGIDKTTLGDYLGEGDEKSISVMHEFIDCLSFINLKFVDALRRLLQCFRLPGEAQKIDRIMLKFSERYMKENPSAFANADTAYILAYSIILLNTDLHSPRIKNKMTKEDFIKNNRGINDGADLDEDYLGFVYDDILKNEIAMKDDQELAAIAPLMNNFSTSSGFTTFTSNGRDLQRVACIQASEEMANKATSVLKKLLYQQKHGSQKTNVYYNATHFEHIGPMLEATWMPILAALSNPLQNSDYVNELNMCLDGFQLVVRIACLFDLDLIRDAFIKTLTNFTNLHSTSEIKLRNTMVIKTLLRIASTEGNNLKDSWKDILTIISQLERVQLIGVGVDETEVPDVINARVRRKNVNIGSSNSIRHVSGSTSRSTRTRSLSKPLSPEAVSELMSTEVVLSIDRIFTQTSSLSGSAIVSFFKALCEVSWDEITSSSDLEQPRLYSLQKLVEISYYNMQRIRVEWSSIWNVLGRFFNMVGSDENRHVAVFALDSLRQLSMHFLEIEELSLFSFQKEFLKPFEYVMASDTVVEVKELVLQCVKQMIQAKISKIKSGWKTLFGVFTFAAKARSEILISMTFDTLVNLFSEHYDTLMQQNCLIDMLISFTELCKNGTNQKISLQSLEIIREVYSSLSTMIKEGLSSKPSVNETFSKYVFPVLFAYYDIIMSAEDLEVRSRALQNLFYIFLEESDDFTEETWEVVSRKFIFPIFSIFGPEADEATVMLRDEEIRTWQSTTLVEALRSLVTLLTRRFDKLHNLLKGYLWLFSNCICRDNITLSRIGTNCMQQLLSGNAYRFEVKDWNLVADMFIELFKETTPHQLLLLETFSNGQGAPVYSENENTQLSHKRGGSLPETSRSISTSSISPEKQMEFRSMIRKCILQLLLISIVAELLDNEEVFNHIPHEHVLKITVAIYDSWQFARKFNEDKSLRITLLNVGFMKQLPNLLRQETASALLYITLLFRLLKTRDPLGKTETDQKIHKLLFPVCAEMLDMYASLVVEKHTRNHAAWQPVIATILDSILNLPLELFSENIHTLYFSCCSMIAKENLDDQLRELLKNYFNRVGHILLNLNAQQE 1822
2 -93.600[U] KOG0931 Predicted guanine nucleotide exchange factor, contains Sec7 domain  ali follow..  17  2..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................MAFRDVTVQIANQNISVSSSTALSVANCLGAQTVQAPAEPAAGKAEQGETSGREAREDASAEDSCAEAAASGAADGATAPKTEEEEEEEETAEVGRG-AEAEALEQLSSSSTSTKSAKSGSEA----------------------------------------SASASKDALQAMILSLPRYHCE-------------------------------------------------NPASCKSPTLSTDTLRKRLYRIGLNLFNINPDKGIQFLISRGFIP-DTPIGVAHFLLQRKGLSRQMIGEFLGNSKQFNRDVLDCVVDEMDFSSMELDEALRKFQAHIRVQGEAQKVERLIEAFSQRYCMCNPEVFHNPDTIFILAFAIILLNTDMYSPNIKRKMMLEDFIRNLRGVDDGADIPRELVVGIYERIQQKELKSNEDHVTYVTKVEKSIVGMKTVLSLVCCSRLFEVTDVNKLQKQAAHQREVFLFNDLLVILKLCPKKKTFCKSVGLLGMQFQLFENEYYSHGITLVTPLSGSEKKQVLHFCALGSDEMQKIAEVTELEQIRIEWELEKQQGTKTLSFKPCGAQGDPQSKQGSPTAKREAALRERPAESEVSIHNRLQTSQHNSGLGAERGAPVPPPDLQPSPPRQQTPPLPPP----------------PPTPPGTLVQCQQIVKVIVLDKCLARMEPLLSQALSCYTSSSSDSCGSTPLGGPGSPVK......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 661
3 -79.900[U] KOG0932 Guanine nucleotide exchange factor EFA6  ali follow..  11  2.......................................................................................................................................................................................................................................................................................................AKVASSGAEEALATIDGAPRRNVKKSEKLLGDQLPPGTTVASSIHPHQLSRATASAGVSFPSMNRNGAAAQKLSRLPVPVSTSQIERRGSLARKTSEESSPTAIRMLKTAPIERMESTDVEESEEETVMMTTDE--------------KENQKKPNENDDEVMVVDEEQFIVVSNDMKSPNEEIVAKSLRSAMFTMPTDNHHHSYNSSPQIS-------------------TLSPHLRSNGDGPSRSPVYDDVDDDLNG-SLDAKDMSNNSHQQSFRSPE----------------------------------NYSEKDTPSKHSVVTIDGSGVSNHYDQDGMFSHVYYSTQDTTPKHGSPSLRKQIFESRTTP--------------NTAASNSSASASPSLHATSESRGATGGVSLRSAESSNLNQTAVPSTSTNSVGGEREAAQIARNLYELKNCTSTQVADRLNEQNEFSFLILVKYLELFQFSTTRIDAALREFLSRVELRGESSARERLLRVFSARYLECNPAIFDSLDEVHTLTCALLLLNSDLHGPNMGKKMTARDFITN--IAHTGCTFKREMLKTLFQSIKDNAISLQNSAKNSTANGSVASTSRRQPQQIYEVDPDSVVEYYSGFLMRKYVRETD----------------------GGKTPFGRRSWRMVYARLRGLVLYFDTDEHPKASRYASLENAVSLHHALAEPAPDYKKKSFVFRV----------------RIAHGGEILFQTSNQKEL-QEWCEKINFVAAAFSSPTLPLPVTSKPETRIPCLAPITKQLSTHEARVAELNEMIEIVSQSVSPNQPQQLITDRWVLLSFEKR----STYINVLRRSLEARKASSATTMNIMMTPTRRQQQNQKPVV....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 801
4 -71.500[U] KOG0930 Guanine nucleotide exchange factor Cytohesin, contains PH and Sec7 domains  ali follow..  26  14...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EDLSLEEREELLDIRRRKKELIDDIERLKYEIAEVMTEIDNLTSVEESKTTQRNKQIAMGRKKFNMDPKKGIQFLIENDLLQ-SSPEDVAQFLYKGEGLNKTVIGDYLGERDEFNIKVLQAFVELHEFADLNLVQALRQFLWSFRLPGEAQKIDRMMEAFASRYCLCNPGVFQSTDTCYVLSFAIIMLNTSLHNHNVRDKPTAERFIAMNRGINEGGDLPEELLRNLYESIKNEPFKIPEDDGNDLT--------------------------------HTFFNPDREGWLLKLGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLSIREV-EDPRKPNCFELYNPSHKGQVIKACKTEADGRVVEGNHVVYRISA-EEKEEWMKSIKASISRDP............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 383
5 -17.800[TDBLU] COG5032 Phosphatidylinositol kinase and protein kinases of the PI-3 kinase family  ali follow..  515...........................................................................................................................NSFCLLFDERSLFKIPYHELFCALLKNPDIISSSVKQSLLLDGFFRWSQHCSNFNKESMLSLREFIMKALASTSRCLRVVAAKVLPIFIKGPNNLDIVEFHKEAVENTAILETVILSWIS--LSRVVEEEELHFVLLEVISSVINSGIFYQISVWQLLSIASLFAQLMNISEGDFLIRTQAYTLPFLVKALIVRIAELSQSDVATLCLTNMHKILASLLTTDHPNLEESVMLLLSLATSDFEKVDLTSLLRSDPISITVELLQEKIENALRKVAMIVSQVVNDEDLSNKELLYDFFNNHILGILAEFSNILNDLKGKTSINEKIKTIVGIEKMLSLCGGAVKLGLPQILSNQNEHLRFYAIKAWFSLILATKEP---EYSSIAGLSLVILPP-PYLEPQEAELVIQIFDFISSDTHKCLQGLKW---------------IPTSLDSACFSLKAKEIFCSLQNEDFYSELQSIIKCLTNENEP----------------VCYLGLQKLELFFQAKVDELHDTL---------------------------------------------NLDISNEVLDQL-------RCLLDCCVKYASTNMQ-ISYLAAKGELGAIDPSRALKFILD---MQSQLIPAFLVTTDTKAQGALQEFLKLGGFKSASLPDLSKRVLIPFRYP--LKLMEYAHSQNAEKIFGICSKVVKDQEPCFLLPFLVILTESELEVNKVIEEFQL-NQPGPDGLNSVGQQRYTSFVDVFFKIVRKKRNWDRRSAIARKENRYMSVEDATSRESSISKVESFLSRFPSKTLGIVSLNCGFHARALFYWEQHIRNATAPYAALESDYRVLQEIYAGIDDP-IEAVSLNFHDYSDQQLLLHENSGTWDSALSCYEIIIQKDPENLLNSMLQSSLVLSLDSFIINDNHEYSKMLNLG------IEASW--------RSLSIDSLKKCLSKSNLESFEAKLGSIFYQYLRKDSFAELTERLQPLYVDAATAIANTGAHSAYDCYDILSKLHAINDFSRIAETDGIVSDNLDIVL---RRLSQVAPYGKFKHQILSTHLVGYEKFENTKKTAEIY----------LEIARISRKNGQFQRAFNAILKAMDLTIEHAQWWWHQGQHRKAISELNFSLNNNMFDLVDEHEERPKNRKETLGNPLKGKVFLKLTKWLGKAGQLGLKDLETYYHKAVEIYSECENTHYYLGHHRVLMYEEEQKLPVNEQSERFLSG-ELVTRIINEFGRSLYYGTNHIYESMPKLLTLWLDFGAEELRLSKDDGEKYFRKKSLELMNSNVCRLSMKIPQYFFLVALSQMISRVCHP---------------------NKVYKILEHIIANVVASY----ETLW-----QLMATIKSTSQKRSLRGKSILNVLHSRKLSMSSKVDIKALSQSAILITEKLIN.................................................................................................................................................................................................................................................................. 1988
6 -15.800[O] COG5021 Ubiquitin-protein ligase  ali follow..  4.......................................................................................................................................................FTRCEKARKEKLAAGYKPLVDYLIDCDTPTFLERIEAIQE--DRSRDDL----IPILDRM---GLLLKVAEKYKYKQDPKKECEVKLVEM------EAHDVDYCLKMLKFTRRLLLN------TENRFVYSSGDVLMYLLNCPNFTIKLAVMR-----ILAILGERFVIAREKIVAHNIFGDHNLRKKTLKLALSLSSSVMDEDGEHFSLVDLYFDKKKVPQKWRK-------------------LRFTHYTSNDFKKSSQQKNNINETQTSIKKVTMTTQELCEHSLQQIFDKGMALLPAESWFDFSIKASVAKAFSDDSGENETKLNAIAFVNTIFSPPQVSSKLFELDPYAFNSLTDLILSETKIPKELRTDALFTLECISLKHVWCSDIILGGNISHGLLFQILRYIAKTLREAT-------------------DEIDEEYNVRFFYLISNLADVKPLHESLFAAGL----IPTLLEIVSPYKRTLASATHLLETFIDNSETTTEFIENDGFTMLITSVANEIDFTLAHPETWQPPKYSVVYYSISFRELAYIRSLLKLVLKLLSTDSGDRIRNLIDSPILVS-----LKKILENKLVFGLTLVQKVI-NSEPTIYPVLVYVIDNFP-PSAELLSLLPDVVSAICLEGEKGLINNLFDFLLDDHAR----ILTGGDRSTEYGTDIDEL---RHYPDLKANI----------------------VEALCNVI--RKMPSTFRNEREFLFTSPKDQKYFFHRKNEEILTDKEEHEPAYWELLDKGTMLDTFTS-VLFGMSLGNGSFSQVPQHLEARDFLAIIFMENPPYVTEVLQYLDEKYEDYAFMDVMKVLNDQLENLNDFLNSPNDRSFFLERDGENSVRSCH----SKLCRLAAILNIVTN--SYFDKRGFSLIKNLKLLFQKCALEEMYIRQHMPDSVITETMPLPIVDVSGDGPPLQIYIDDPKKGDQKGKITSVKTRNTLQMRTILY-NTAILFRCFLRLDLTTEVHIFENVVENVIEMLKATELEGHLPYILLQTIPAYIFYQKGGYLLYLHIIRDLFTRMTKNYIDESNGILTLSCLINALTFYNKSMQTETMENVQSIGKYYVS-DYNIMKALTVPIKVMALAMILDLDKSDSLFKTQSRNVPYSVFKQLLSELHWDLIFPPIKKISLFEQVGIPGDVAANYLTDTSKELDELRDTFFNDGLPSRIFTVLPFYPKLVNAFAKTLLQIFTKYDEPTEVFAGRILDRILETDLDDPATYIYQKASHLMQRFIEYLEKSLKPEHVNTPWFSKALYVYEIILAKSELPHLEELSKDVLL--FYSALATSRILIFYSRDE-GILSRLLESSFLLLTRRCFETTENVDALIRAEINRSFTARPLGGGDDAVRELTTILEEKAHVVMPSQFIDVLCETARFHEFDDQGALVDYSLKRFLGEKDKNTQASSTEKSDIYERTGIMHLLLSQLMAASEKDWLSEPANSSDLPENKKAQLLLKLLVELVSSYTFSRRNTYAERPRPRTTAINFF--LYRLLKRREVIGMLARSVIIGFLATVQDDRTTKTDVKIRKFAIEAIIKAIRNATSSSKLLESNKLDMWFRIITSMVYVQYQLCKLVIDLG---LPSVITEAMASIDLNPFSKKIFNVAVEALNTI......... 1864
7 -14.800[S] COG5543 Uncharacterized conserved protein  ali follow..  12..................................................................................................................................................DLESLPSQPTVSSFQQLRETFIQSKSEDWYLKNGLFFRYYSFLKSSLENATGPSQVACLDTISVWLR----DPEISKYVWDTMELKFWTNLFSLPANKISIPGLTGVAVKDVFSKSLQLYLLVCPSEDIKNDFLLDSLKHALHWDRHAKVVLVKVTGAEAVFAFQPDFFEQSLKLLKDYSYAQAISSTILTVLTLRFKSLSEETEDREEVETK---CPIILYEFYGNDRQVQAGMSSFLIPSLLGVSPGITVKFLSRLQNYPNVSKDAIKNLDLVKEHAFVKTLFKHPDIKIQLACFRLIALCPNVSSPLSFEDFDCLESNIEFSFNVLDPDSRQILLKSMQDFFIRLRASCHSRAMQFLTSFISVCKKHPTCNYQQVLVSLSFLDTLISDRDLSRLM-------IDRLKDPYDDIRNLCLKILLSYKSLPGFISDSDAYFLFNHGLELLNAVRSHECDGGAKTIYLCNHFMEKSVPGSVLANTKVILNRLKS----------------------------------------------------------------NIEHAKTSLLEAAV---NCPLQGYLIQLTY-IFQSLSPTIVKNDNESWKNIVMELI-KASETIWGLIKDVLCD-EGEGGIVSNLEDTPAQLILSSWRSLKETSSL---LTVLLTKCLSLFDEEFTPFTLNYYGELMMTWLWEIRHRGAFTS--VYPCFIEYCSFLFECNKLPDPWLHKNLSVIQEKSSFITRRSGG-----------IPLSITAILVAGKDKREQLIEQTVISLISIAKQ------PVEQKNIAGQFDLPQVHAMNTLKTIFT-------HRLSSVSVEY--EPAIALSIEGFSHPIRNCSVM----LFTALINRAFGSKKPKDAVNLGNNKGLSTKMFFS-----------KFPTLHDYL-----LRELEVSVASLSSNDQPSTGL-----------------NMFSRLQYAQPYGNENEWTGLSQFEPLIFKCTASRIC-KVREIASLSLTCLLTFIVSQLKGVAGLQQNEIHGKLLTIRAVLSFSKLTLQQVQEFYEVVPLAFINCFLEFTSSKTSFYAKKLFLEVLNSYFMSNTDSNAKRLQQLRRMTMDYCKRMLLDRKANVTNVFNTIGLPIHQQMAATIYCDAHSIGFLVSKLLHYEFYEVQLTTLRSIVDSPRK-----KIIVNNPEILQALIKLTPRNQWSQVRALALSLLSDSLNSTSYRLLGI-----------------SCSDMVSNILSNECLPIKESFIVLLGSCIKQLKTENFLEY-----KVTFAKWVEILLS---------SNEYQPFSSRKAALDSIIHFDLFNAE--EAFSFEFYILYLLLGDFLNDDDEEIRSLAANHAYQVL----------------------------------------------------------------------------------TSAQCVTEIWNLWKLRTKATFGGQHDFQHCINKRLILEDGCELASVQLDNALSRNCSL--------FERERQNLYYSDNQKLEDLLFYASYPN----------------EKLKDWATDGINAILSRFEDVSRDGPLGKTSHVHLPLDRVHSLMNRI------DGHPSFCQ.................................. 1502
8 -14.500[DK] COG5103 Cell division control protein, negative regulator of transcription  ali follow..  2......................................................................................................KSQEQQTPETREKSSSTSESGHPISLDSKTPPPNDSKIESIVKAQILFLLSTLREDQYDTKLEQIRQLINKNAPRVYH---HFLRRLIQGNSYRIFGTGKSSDGLATYKLLLDELKSLTKSWVMAKRFSDAISGSDSEVFEDFDIEAFLDHFQFSPLRTNLLIGLTTSVKPTLAKKALKNTFQSLLNQLSDPTQSIDKNDLDLLREGLFTTDYDRIPLIKVPKFDAIIEKKLANSRPLTALFGPMKASKATLKSMKEAILKKYPPGTATETDVAYLINSLVAIHDYGAWDTVLMGKAIVSSFEN-DNPKFMITGTPSLVLFFTIFTNAYKLRQTNFTLDFLWVLWRNPLPQLSIISHIILELVQILLRLLSEVVTFLNFLDEELLLLGTLQLPLAWNPVQESLAFQWCSDFFSNFKEHKTNPQFLFAFLRSLWLKDSSSVNQVVEFIIENDFTSHIGNEIAALAAARKALSFQDWLDKKMLEFEDADGLNVFLVEVLDFLMSRAALQKNESEQKEESVVLSIDTVNVLLTTLMDNVSISEEVSEHIKDVQILCLQVYPRLFSLGHDRDSIVIATNTTNSFSPDVESEVES-------QALYERRISIGKIVLTLQNFKKSENP-QHSLFDE------------RFFPDYPLEALALTAVLFGS-------IQFELL-----SFVPLGVALRYVYQALLMPTDSK----------------------------MFRFGMQALV------QFQEKLPKINYCNLILGIPSLQLVRPDIYDSIREMIASNENTEVEKDKLDSFSALANPASPKAPEYTFVSVCDNILFAINNLSQLNFNEKLKDVKDNLTQRVSREANFLSLYGKFLEELKSSDLYKIVFRDTLQAILDIMNLSPSEKTNLKNLGSWLGSITLL-----------ITTLQVSFKDLLLEGIDSGRIDRVLPFVCKVLESSSVIFKNPWMGILKLLVELYQFADFRLNLKFEIELLLNNLNVKMDNIEPSEMYRNHLVQKADLEKELPEDVLNAEFPDGTDVITQYIVAASSQITVTDAVAQVQQSVLEIISAVVRRSVGIAAITTKSLLQKDFAAES-------NPSRLLLAARQMAKTLAGNLAMVTCRE---LQMLMINNFRTIALQDVENVHAAVAQAIDELVSQNLFVASSVIESVASETAIAEIDAEIEHMIVERVRHRK---VLKLSSELTPQQFQLYENFDRLSLSTIMSNNSFTSLNGLRTDSADSTDALNSNLNNTVENEANQTALNYARNLLIIIGQLFQLAAQMPYTSMQ--HELVNQFLTGVASINHPIADHVFLLCAQECCRILLTDSKSPFILEVFSAILEYICQTKTAINVSLYWNFSNDLEKLNLPIILSLIRFGILTS-----GEVDYHVARGVR------EQGSGPVTDFAIELLRTAVGGENPMALPGNFVNSITSLYEISESFSGETKQAYEQLVETMNKSVSPASEILSDLDNKQQLNDQIIIVFVSWVHLLRNSATNDETKAAFVYQLQFFRCNLEAVLVAFLEAASVNAPDYFNVDAYASLLVNVVKYTEGSTEGTVSSKSVLFRKIIALIMAEFVHQKTFFRLFSSILSE------DDAKDVLESCFVDIYSVILECFLAIQPRSFPAFTFAWLSLI-YLLPKVLLVNNDK-----DLFSEILMSFLKLDLKDDIDKAQFKLLYNGFLRIILVL..... 1821
9 -13.000[A] COG5181 U2 snRNP spliceosome subunit  ali follow..  2......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................STVEDVEIERLRAERELLRRQKEAAKNSSTNG-------------SVNIEGTQDSNDLQYNAHLFKEYIDVRNDIS--------DEDDYKRTNDVNDSYRLVRQYEAP------KELLNEYADE----SYDPMQERQSKKQIQ------ESDYQKQRYDRQLTVDAFQPDGTQSNGRS----------YAEVMRQVELEKEERRVHMELNQRRREGTLKEVEEEESISDKKRELELNNTQKPKRSRWDQAPPSVTQVSTTKRRSRWDKAPENFTISEHVIENGISEDLINKEVNVVEEKLRPPVRLLTEEELNELLPIPGVGDLAFFKQEDVKYFGKLLKVEDEAKLTIAELRKILRLLLKVKNGTPPMRKSALRQLTDQAR-QILPLLMERTLEDQERHLLVKVIDRILYKLDDLVRPFTHKILVVIEPLLIDEDYYARAEGREIISNLAKASGLAHMIATMRPASALGVPALLPFLKAVCRSK-----KSWQARHTGVRIIQQIALLLGCSILPHLKNLVDCIGHGLED----EQQKVRIMTALSLSALAEAATPYGIEAFDSVLKPLWSGV-----QRHRGKSLAAFLKATGFIIPLMEPEYAS--RRIMKILLREFNSPDEEMKKIVLKVVSQCASTDGVT--PEYLRTDVLPEFFHCFWSR-RMASDRRSYKQVVETTVVLAQQVGSRQ----------------IVERVVNNF-KDESEPYRKMTAETVDKVIGSLGVSEIDERLEELLLDGVLFAFQE---------------------SVEEKVILTCFSTVVNALGTRCKPYLPQIVSTILYRLNNKSANVREQAADLVSSITIVLKACGEEALMRKLGVVLYEYLGEEYPEVLGSILGAIKAIVSVVGMSSMQPPIRDLLPRLTPILRNRHEK-------------------VQENTIDLVGKIA--DRGSEYVSAREWMRICFELIDMLK-----AHKKSIRRAA-----VNTFGYIS--KAIGPQDVLATLLNNLKVQERQNRVCTTVAIAIVAETC-FTVVPALMADYRTPEMNVQNG----VLKSLAFMFEYIGEQARDYVYAITPLLADAL--MDRDAVHRQTAASVIKHLSLGC........ 1083
10 -12.900[K] COG5221 Dopey and related predicted leucine zipper transcription factors  ali follow..  2.............................................................................................................................................................................................................................................................................................................................................................................SLPLKPLTIDSNNKQLDSKQKKFRANVERALERF-------------DSVTEWADYIALGTLLKALQSWSPKFQNVRYYVPSPY---------QVSRRLTSSLSPALPAG---VHQKTLEVYTYIFEHILETLATECNIWIPGILPLM---TYASMSVRSHLIELYDNYI--RPLISSLLPGID---DESNDFLPLTLKLIETLQENLDDDS--------------------------------QTLFLVMTANKGRRLGGLTWLTRKFPSLNAVPHLVNKIKMEAEENPSETETNDSHLDRKKRKEEAFKVLLPAAKDLVTPERCLVGCLEDENDILIKRSVLDLLLQRLRLDSPVLNVLITSEDKKLLIMS----CCRTTLSKDMSLNRRIWNWLLGPTAGGMFRISMAVMDRWEIGSLVIPELFIPLLYSSEKFKQNEQIMKTARTF-----------FDNTETNIIWGKLFQELED-------IKNLKILDFVLTNFNIGNDEEIIVRHLNKLLNYIPERALLPLSHSKLKHDDEVSCEELLAKIRGFYTNVSNPSSILEKENIAERLPPFTTEDLTFLIADLIQKKLLSSLWDLENINESSKLFIAIF--EKIPESEELKGRSHISWSDKKITQSIFEAIPRLCESNNDAKSEEIVGIVEIFGNYLYSRMEFIESMKLLKVVMMAV----------WKSLVKNLKTLNRFSALVYTFVEEEDISERLSVLDL---TQLDSDSNLIRRPLELILGELFDDQNPFYLTVSKWILSILNSGSASRLFQMLAYVLKTNNGRTRKVFSTELTSIKSSTIWKNEDVSTYKSLLLVTLMRFLNIKSNTHAKSIRSALILLDILLDGTEQNFKDIVIF-LLQMSSKYIAEEGIEPELIAVSLLDIVSKVLRLSHDNGIKLYIDFLVTSVSNMKSPLIVTAYVKLLSESIVYFENSIFRMILPLSASLVQCVQRLFLLEKREGGYYQPIALLLGGLE------------ELLEISHGYLVTEEREGYFSGSNLKGDFIQSVVSNVFSSDSSNEESKIQGERDVILQSFRQVI-----------------SCCLDIWYWAHNISCKSNDDSSLDATNHNSYKFKFRSKKLLETLFLELLENLISIRSDIPHLLYGVIIRYNRTASVKFSNRLFNYVDSVENSAMEEFYGDFLLFFREVATNYNLYSDVSLSILKLVALISGKVSKTQFGEQKRVRREISDVFFKYLPNAFINFTNLYRGHPDSFKDLEF-VVWRVQYIVNDQIGGDKFNTTLATIVNQCLTPYIKPKSEKTIPGYVLELAAVVSHLGSKVKSWRLLIGSDQTWEKIIWSIYPENKSKILNDLLLEIGSKRSSVTPTLITFNLGSDSEVEYKCQNLLK-ISYLLMVS----PNDAYLLHFSSLISCIFHYLVSKDLKGSCWILLRVLLLRFSESHF....... 1543
11 -11.700[YU] KOG2023 Nuclear transport receptor Karyopherin-beta2/Transportin (importin beta superfamily)  ali follow..  6................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DQHELEQVIQLLQHAHSTDQRNVQVQLVQLNEHQ-KFCCYLVYILSDMKEMIDATSRS-LAGLLL---------------KNNIRAKWNKYPQDVKFFVRTTCLKSIGDQ--EPLIRATVG--IIVTTIVMEENMCDWP-DLLDTLATVLMQPDELMQE-----------------GALGALQKVFEDSADRYESEFLRPIMP----KLLVFYEHHAAKMRALAMNCVNCILMVNNDPIDFAIDQFLTSLFARHND-NDEEVQKQLCRSLTLLLD-----THIEKMMPHLPNVIEYIIKKTQDHNESIALEACEFWLSIA-ENSDICRTMVLPHLDKLIPVLLGSMRYSETDPALKANDEDSSVPDREEDIKPRFHKSKQHGLGGLVESDDEEDEDDDDDGGGD---NIRRCSAASLDVLASIFGKDLLDKLFPLLKDTLMND---NWLVKESGILALGAIAEGCMDGV-------VPHLGELIPFMLAMMFDKKPLVRSITCWTLSRYSSHIASDENFRQQFFKD--VLANLLRCSLDGNKKVQEAACSAFATLEEEAGEQLIPFLGEILDQLVKAFQCYQAKNLLILYDAIGTLANSVGDALSHPVYVQMLMPPLMEWERLSDEDKELFPLLECISAIVSAMGQSFLPYIQPVFTR----------CCSLIEKCVQQNQQHIMAPDQVEAPETDFIIVALDLLSGL-AESLPEHMDPLVANSKLVELMLFCSLDVTPDVR------QSCFALLGDLTKACPERVLPQSSNFIFFLAQNLDPSKISVCNNAIWALGELALKMGPAMKQ---------IGPIIEPLIVVINSQQNMQRT---------------------------------------------------LLENTAITIGRLGQCC-------GEELAPHISRFVRPCCYSLRNIKDNAEKESAFIG-----LCNMINMNPVGVLNDFIFWCDAIAS------TVPTDSLRVLFAGILQSFKQ---QVGDFNWNNFILQLPPPLRERLSAFYQI.................................................... 883
12 -11.200[YU] KOG1993 Nuclear transport receptor KAP120 (importin beta superfamily)  ali follow..  1.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MQVDPVVYQLQSQDPIAVKDAEGHLNNWK-KEPGFFGKLYSIFLDKQNDMSLRWIAIIQLRIDIIWRKNTKMSLLPEERDFIRCNALLGSIKSENLLSIQNALVVSRIARL--------DYPTEWFHDLLGKLQQ------SLGTGDYDVALRLLITLHHIIKAMAGNRLLRSRQIFYKLAPELLTILQPILHSSLSSWMMILESSKEIKDSTLLSYMQ-TLKACRRLVVFGFQNPSESEFSERMLAFCAVHQRKLLSMLGTMRSPIVVGECLEMAFAHAFLFNKPFFDFSFYSPCLTKFPATID----------------YISLHYDFLGQISSHLSSYKEKFEESSKNFEKLVIMSLRVFILVIQEFCNTKSSHPETAQVLYNSFLVDNRINNLLDLLITKLLILKEEDFEEWTDSPQQWVLEQSTQDVEFN-VRPCAEKLLKCFFDAYGDIIV---SPFKDMIYSVFECPKTLTQAVQQDTLISSFGVGYTQLKSIFPFAKW-LQEAAVPNMASINDIGISRVYRRRIAIFLSQWIEDSSSEQLLEYKLYCSFLNLTDPCNDAVVILTTIDAFKTVLDDNFSENSFLSIKENLFVHVLSLFKAFESVDARTSILSLLGTLLARAGEHVAPMEST--------------IASLLSQLWDGWKKEPLLRARVLAVMHQFVNAIKAKSF-----EFSTFLYTVIEYCVNPESPE------------HVIFEADAMELWSTF-LMYIQKLPETFTLLIPHLLYHLSQATSTL-PFVLMIVSSYQLLDNTVLMKDYSFTIFEKLNDLLDDVKNE-----------------------------------------------------TLQALCKTVCLLIETTPMDMIYESLLNSSL----LSRLLLSIATN------------------------------DKHPQVLIEYLLVVSRISLREPEL---KVCQTKNINIAMLIGNWILLNDHINHSKDRK-------LNTLALSSLLRTNHPDVLAVLDSIMNLWFSVL................................ 891
13 -11.100[U] COG5215 Karyopherin (importin) beta  ali follow..  1.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MSTAEFAQLLENSILSPDQNTQLKKLSNDNFLQFAGLSSQVLIDENT--GRILAALTL---------KNELVSKDSVKTQQFAQR-TQVSPEAKNQIKTNALT---ALVSIE-------------------------------------PRIANAAAQLIAAIADIELPHG---------------------AWPELMKIMVDNTGAEQPENVKRASLLALGYMCESAD---VSSSNNILIAIVQGAQSTETSKAVRLAALNALADSLIFIKNN--EREGERNYLMQVVCEA-----------------------------------------------------QAEDIEVQAAAFGC-----LCKIMSLYYTFMKPYMEQALYALTIATMKSPN-----DKVASMTVEFWSTICEEEIDIAYEL-AQFPQSPLQSYQNEDPEDDDWNVSMSAGACLQLFAQNCGNHILE-------PVLEFVEQNITADNWRNREAAVMAFGSIMDGPDKVQRT--HQALPSILNLMNDQSLQVKETTAWCIGRIADSVAESIDPQQHLPGVVQACLIGLQDH--PKVATNCSWTIINLVEQLAE----------ATPSPIYNFYPALVDGLIGAANRDNEFNARASAFSALTTMVEYATDTVAE------TSASISTFVMDKLGQTMSVDENQLTLEDAQSLQELQSNILTVLAAVIRKSPSSVEPVADMLMGLFFRLLEKKDSAIEDDVFYAISALAASLGKGFEK---------LETFSPYLLKAL-----------NQVDSPVSITAVGFIADISNSLEEDFRRYSDAMMNVLAQMISNPNARRELKPAVLSVFGDIASNGADFIPYLNDIMALCVAAQNTKPENGTLEALDYQIKVLEAVLDAYVGIVAGLHDKPEALFPYVGTIFQFIAQVAEDPQLYSEDATSRAAVGLIGDIAAMFPDGSIKQFYGQ-----DWVIDYIKRTRSGQLFS------------------QATKDTARWAREQQKRQLS........... 860
14 -11.000[OZ] COG5234 Beta-tubulin folding cofactor D  ali follow..  10  31........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DDRSSSHSVEKLKDVAVKYLQFCQFQPT----------LLDK-----LSKYV-------PNLASYLLKVKNIGKCNSITVIL--YQFCKIRGYKAVRVL-----FPVGVQYIKELYTLLNEHYI--TPFPLNSLDDSLDVKKTIYTIAIKYLENSGIDKEASCLVLSRLFSRDDGLDLLLGFLHHCESSWFKRSFLKICPRNDCLQTVDVAFQFLNVAREDLVGQENSALRKLLCKCYTRLGIVLLPVNSSPNWKYSISNPDSFFQLPDDSNEEVHIYLEVIVDFLLSSVS-----DIDSFVRWSAAKGLAKIISRLPWNLAEQVIDAIIELMTENMFLNPIENTVNISITSP---------------LVWHGAILFFAKLAGAGLIKYSCLHILPLIEVGLSYEVRYGTRVTGQSIRDASCYFVWSFYHCYSKSAIEGLQTNLILCLLQTVLFDN---NVRRAATAALFEVINCYGDLCMKVAHFPQFRSCVFQRLFTNLQQLSAFSLRQLSIKYPKELSIYLPPILDYLSVGNADFIFGYTIGLASIIGGFLSISFPFDINRIHDLLSHKNLLSLKKFSRQQQTKIILGILKGIQQIFAN-RAFFSEAFSVIIAAIDLQEETIIKDISDAYSVLVKFDDM--------EETLEVLLDYIRKCSTSKEARIVYIILQNLPNISFRYQKK------------------ICKLLLDIYPQLHSIDYQAPVANALQNIIPFTYEK------TESIEEFVKELLQVCSNYLT-----DTRGDVGSWIRKPAMKAISSLLVKDSSGKKLSEDIVWCCISYIIRQTFDKIDSLRGLAYQALEQIRVHYLIRRCEALTNIINRISFRNNPNMDGEVLNELNISLLEIPNLRLQAFYGITVFTADGFGSDLAVKCFEFYLSYVYQLEDSFKKSNSRYGKRDLLQLYIDILSSEDEIARFYFP-IMKSFTSLLAYGCFTDFQNVKGMSKAIFIVQRRALTCKSPGG-----LSAILELYRTLFLSKNELLRHHALKYTANLLLYQAADTL--LYAKSIGLLTFLPN-------ELNQKLLTLDWFVPVSQNATFVKQLRNIIQKQ............................. 1099
15 -10.900[U] KOG2081 Nuclear transport regulator  ali follow..  10  1.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MDTYSVD--VVYQAISALFQG---PKEQEKANKWLQDF------------QKSIYSWTIADELLHQKRDLH--TMRNKIQNS------------SELPPHTHESLRDSLITHIGQIDEQTDNVIV--------------------------------TQLSLAVADLA----------------------------LLMASWREPINDLLVTLAP--HQCAIWPLLEVLKV---------LPEEIDSRYLRLGANRREEVHKQLDASAECVLKFLCMCLQREDLDQQRVWNAALRTYSAWLVIHAFPVSHVYNNALTQLAFRLLSLPETSGKLHDNATECVCALLSCINTRQDGASDPESSFEAQLFGAVCMLETPYHLSVAHEDTNYCRIFTSLCDAFFYDLLADAQKPHYSLKGLDLVLLCVGHFDYEVAEITFHLWYKLSEDLFQRNEDKLTVLFRPHIERLISALFRHSQMESDHDGL-ENNNFFDFRRKVSDLIKDVAFIVGSGACFKQMFHILQAPETTWESTMQNVAKNILPDENEVIPKVVEAILNMSEQTHIAVRYT-----AILLIGELCD-ENHPESLEAVLNFLLYALQQKNGLAPAAAIALTSICSACRQKMVCHISGLVEIARSLDSFQINNDVAIGLLKGISLILTRLPREQLQPALREIVGFQLQPLAQLVDSTGSTPQKGERVYWIDRACAIIRHTNPDVPDNVEHPTVAILNDAWQLISRVMDKSDLRIMERTCRLIRYGIRMVRKQ------------AMMLVEPLIKQMVVLYSVQHHSC-----------------------------------------------------FLYVGSILVDEFAKSSECIGGLLEMLQAFIEPTFGLLQMENGLKNNPDTLLQSSLITPI--CSLDHREANSSVMKFFINLLVSNNHSRNTECRPLVVELASQHGGALVMNLIASVFQLHSYMLVDVAEVLHELLEALPKKNSGGYVTATQQQLDEFSSTVLRADTTKAISQALKTFTRLF............ 913
16 -10.700[YU] KOG1241 Karyopherin (importin) beta 1  ali follow..  1.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MTSDIAMQL--------IAILEKTVS----PDKNELLSAKNFLEQAAASNLPEFLKALSEILVN-----------TANSAVARMAAGLQL---------KNHLTSKDEKVSQQYQDRWHQFPSEIRELIKNNILA---ALGTENTRPSCAAQCVAYVAVIELP--------------INRWPMLIQTLVNKVVSEGSSEMHRESALEAIGYICQDIRFGVMENQSNDVLTAIIHGMRKVEPSNHVRLAATTALHNSLETKSNFEKDMERNFIMEVVCEAT----QCQDSQICVAALQCLVKIMTLYYQYMEPYMAQALFPITLA--------------------------AMKSDNDAVALQGIEFWSNVCDEEIDLAIESQEATDQGR---------APQRVSKHYARGALQFLTPVLVEKLTKQDECDDEDTWSPAKAASVCLMVL------ATCCEDEIVPHVLPFIKENIESPNWRFRDAAVMTFGSVL----NGLETNTLKPLVEQAMPTLIRLMYDSSVIVRDTIAWTFGRICDIIPEAANETYLQTLLECFVKSLKSEPRVAANVCWAFIGLSDAAWEAAVTNDGETPETYALSPY----------------FEYIITQLLETTDRSDGA---------------------------QANLRCAAYQALMDMIKNSPLDCYLVVQRTT--LVILERLNQVMQMETQINNHSDRHQFNDLQSLLCATLQSVLRKVHEQDAPQISDAIMTALLTMFNSSAGKSGVVQEEAFLAVSTLVELLGAQFAK---------MPAFKDFLVMGLKNFQEYQVCCAAVGLTGDIFRALKDLMVPYSNE-------------------------------IMTVLINNLTEPTIHRTVKPQVLSAFGDIALSI-HFLPYLSMVLDMLRVASNLQTDANNFDMNEYINELRESILEAYTGII--QGLKGVDQTAHTDVMHMEPHLMHIISFIKRIAQEGDVSDSMLAS--AAGFIGDLCTSFGPRLYPLLDD--AIITQFLAKRSKAQRTKMLCTWAVKEIKKI......... 877
17 -9.960[R] COG5219 Uncharacterized conserved protein, contains RING Zn-finger  ali follow..  2............................................................................................KKKSTDLYGRKNPGMQSMSGSFSSLQIALDESSSNFSTIYEPPDLSGLDAEMIVIVKNLQKRDIVTKCRALQD-LIQWNDPSQFDNEQFLNALAVLFPRLSIEVERHVRLKIFVFMSVLSS-----------ALQKKLAPWLKFYITPWVMGFFD--SDRAVSVSAKDSFKNLLSEEKWPHVWLGSTIAPIVTDVF--SLTDLRFFSNEEAESKVTRVKSSCLLTLSFLFKQTADLENLETDKKIDKQTFKSSLYENLSTLFKSDEFWSLVSSPQDGVTVSLSDLLLIILKYDKPFVTQYKEKYFKRVSRMISRLTSLTCVPM--------LRLLSNMISNFPNEVHQFANDSKRPLSKLFSNLITK-NSGFYTSLLNLFKSIGAMQLVPSIESVDELCDAFLETANQEYDCLLNFLSFVYTDSSDPQIKDRDRLRTIFTRYFKGEFVLRCSTSDFDHCLQSVFDKNSDFASLWNEVLFGFFNDESMDIETIPFDSLSRNLSLTVQTVLY--------LKNRNFQTGNEVMSILGPCLSFLMKLSTHKNERIACLSASQLITVCHIFSDTTLIKPVKELFQKYLVNDLPSSILKLGPQSPAFTLDILLLLKDYADLSEPWENVANQFTVSFDELENIRVLNSLPSLFADGKLRGKISLVKTLVEYYDTAVFAQNPGNDWDMIRACIGSKEVPEETIKNILFTTLEYFLTNDWVDNHLIILCASLHSLKAHLPTIFDENKSLYSLLPVILFSKPEDDGHVAAHFESIFSLLKEK--ALEDSGFSLKLCSEVQEWSLNKVLNGSINEKLAADKCVLVFNSFGKLPSNFFTFPASFWDAKISSCIPFFSNKLFIDQDFILGFLDLVASEPINVDMTDVGTQFVHIFHAS--QNGIQSIIDVPIRDAGIFVESFECYFKGEVVKFMR-DIDGKMPVLFKRFKNLSSAENTTSFSIFAAQGLTDFLIVVSNLLEMDEKHVDVVLGKLGLSSSKSPI-----------FVSSILEGLKPLEVDSEIIQRIRFKAVNDLTGKLHSANEVSKSLLILNAATTQQI-----TEKPLLPITRCRLFLENITNWCSESGIKSLELL--VCCFLRFMYYFLPTVFSLSGSYWNSIFDYIKYAMKMSVVDAPIVKALRLYNALSKNYEMNSDIKDCIVESNESMNYLLLKRFLFTHESTLRNSVTARMCNQYLVKLLENCPGK-FQYQEFFPSLCNSNDLQMESVCMKFLREKLSHELKELT------------VYYMVESDYEPDVSLCPELLSLAIDFPGDPFVMVSKMEKYEHALRVYLWDLIFYHF-----EETTYNIKLSIINQLHA----------MDLLRPLLN-TLVEILNLSYDRPINVDKYPKIDYNLMDYSSATDRIRCLAIHIYYQCLRHLSSSWSEVKN------RAFTSTVESFTGYNVSPLLI----------------------------------SASLDDVERSIESEDFQSVGDVNVKVNRNTREISFIYNVDEHKLEMAIKIPSVYPLQNVQVEGIERVGVNERQWRSLASQSILSITDALL-KKNISMHFEGVEECAICYSVLSVERTLPNK-RHKFHA-----SCLYKWFKSSNSSR-------------PLCRSSFTF.................................................................................. 1609
18 -9.840[YU] COG5101 Importin beta-related nuclear transport receptor  ali follow..  1......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MEGILDFSNDLDIALLDQVVSTFYQGSGVQQKQAQEILTKFQDNPDAQKADQILQFIADKLITRKWKLLPNDHRIGIRNFVVGMIISMCQDDELINKSTLVQILK--------QEWPPEFIPELIGSSSSSV-LLSEE--------------------VFDFSAEQMTQAKALHLKNSMSKEFEQIFKLCFQVLEQGSSSSLIVATLESLL-------LHWIPYLELLSTKF--MTSPDTRAITLKCLTEVSN-ATYANANGNDQSFLQDLAMFALLESDESLRELLLNAHQYLIQLSKIEERELFK-WHNLVADLFYEVQRLPATEMSPLIQLSVGSQAISTGSGALNPEYMKRFENMVRPEEVLVVENDEGEIVREFVKESDTIQLYKSEREVLVYLTHLNVIDTEEIMISKLARQIDGSEWSWHNINTLSWAIGSISGTMSEDTEKRFV--VTVIKDLLDLTVKRGKDNKAVVASDIMYVVGQYPRFLKAHWNFLRTVILKLFMHETHEGVQDMACDTFIKIVQKCKYHFVIQQPRESEPFIQTIIRDIQKTTADLQPQQVHTFYKACGIIISEERSVAERNRLLSDLMQLPNMAWDTIVEQSTATPKVRGLRTIKKEILKLVETYISKARNLDDVVKVLVEPLLNAVLEDYMNNVPDARDAEVLNCMTTVVEKVGHMIPQGV-ILILQSVFECTLDMINKDFTE-------------YPEHRVEFYKLLKVINEKSFAAFPAAFKLFVDAICWAFKHNNRDVEVNGLQIALDLVKNIERMGNVPFANEFHKNYFFIFVSETFFVLTDSDHKSGFSKQALLLMKLISLVYDNKISVPLYQEAEVPQGTSNQVYLSQYLANMLSNAFPHLTSEQIASFLSALTKQYKDLVVFKGTLRDFLVQIKEVGAEDKENALMEQNRLEREKAAKIGGLLKPS.............................................................................................................................. 1080
19 -9.780[BD] COG5098 Chromosome condensation complex Condensin, subunit D2  ali follow..  10  6...............................................................................................................................................LSEYLTKFQTTDRESRLQDPSRELNVIIDQLAVSPEDASPDSLEALIDLCHDFPHQLSYLISSSLSNLSK-ANLSSNVNFTEIGGLIPQLIQVLLTFLQDELHKVSSQSTNLLESITKLLEINLSKIFQTTPEKDLFIGLFTRPLFVLLEIEPVTKVSSLKMFIQRILAMCVKNHGQSSSIQSSLMTNLTYFLHLSVFNAELLKLLNDEYNYPQLTED------------------------------ILKEISTRVFNAKDTTGPKAISNFLIKLSELSPGIMLRQMNL----------------------------------VITLLNNSSITLRCSVVEACGNIVPQTMEHYKQQIAVLIELLEERFQDSNP-----RTKAIQGCSKICDLSSKFNKSK----------AKFTSLAVRSLQDRS-----------------------SLVRRNSVKLLSKLLLKHPFKAIHGSQLRLSEWEEYLKGSESQLNSTLKKVESQETLNDTIERSLIEEEVEQDEGQCRTELEGSFNKSAELSRIENEVENINATNTSVLMKLKLMIVYYKDAIS-FIKEIHKSIELISN--LLFSKNRNEV--------------------------LESMDFLVLADAFDIELSEFGIKKMLH--GTNDEGTSIVHLIECYKQLFLTAPDSC-NMQEKAAHIAKNLINL---SIGASIADLASLEQLLGM---MYEQKLIDQHVINILWAIYNSASKASMQKEQNVNNRDSEKGFSKEQIHGSIIILG-----MLSLADNEIALKGLESLLNIGLGAVGLKDLT-ERMVPKRSTIITKAINQELEDVAVKKLYAIIINYTKDNEYYPMCE-----QALSALFTISSKPDILATDLIR---------------EKTMMTFGKPEEEDSILSLEQSSRVVSLSQL--LFIVGQVAIKTLVYLEKCEAEFKKRKIEAETRNGKVKNQGADVTNTTQDNGGDKELEMIGGTNEDDFTDAIQFVKENELLFGEKSILGKFCPIVEVSNSSRFSDPMLQRTATLCLEKLMCLSSKYCEK----------SLPLLITVMEKSPDPTIRSNAVLGLGDMAVCFNNLVD-----------TDYLYRRLHDENLMVQRTCLMTVTFLILAGQVKVKG-----LGEMAKCLDNPDQGISDMCRLFFTELASK....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 1081
20 -9.760[YU] KOG2022 Nuclear transport receptor LGL2 (importin beta superfamily)  ali follow..  1.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MDGNEIA--HAKKLVYDLYSGSLSPSAIAATEKELQKA------------QRSQQGWNIGLF--MLQSKDVYEQFFGALTLQMKINT-----QLETLSDKDLVQLFVQLLQRKVICEEASLKVIYCLFCNKLEFFNADMNAASVLNNLFPPASSRNAQLTASYINELLLELSFSIYTKENEDALFNNVFRPC--SNIIVSVLVFIFTNYSLDLSKEKNVAALEEALNCMIAISSYLAKASVSQSVLPAFTEC--MDLTVNCIALDEVSEKAMNCLADLLANYSNFITQP-ERLWTILTGPWGETHLQQELEDPDS--------------------------------------GEENDYSFLNIVIGFAEAMLPQIIDHIQEEKSIRLLYILASLLSFPGYAIVEEKVSWRTLEF-----------------------WTTLIEDFSMSKAATDPSKDEIFKQIAFSVVEKAWWKMLLPSPE-SRDSFNSYRRDLGDSSYSIFGERLYAMYITTIENFFSDGTGSPQSLLCCILEYDTNDSDTLDAWLTRLFETSFAIKASAFQNPQLLKTCSQLLSSCSCFLQNHPQYLNIS-LFDALHISETSIQMTVSRSIHTLCTTCASHLLTEIDGFMAVVEEVYVPSVLEKIYSSVGYVTQR-----DIELRISYLMRLLNCILAQLQP---------SLYPNLEIFENVLKSCLQSVAGVALS--SCIAEFQAKLISFLTHSESMQYSDVVGLICKIMIAGLNEVEPSPFSLPIVTTIQYFCDRFTEFPAAVLLTLGSAILTCPYGQTDIIDK--------------------------------------VLIDMCSSIQNSVVIINEESFMNNIDITVELYHFFSIILQKHPSETMYPDFTQLILNRAIN-----LGKPERLLESAAGQFIISFITSEKSDLLNTHTDFVNAIRSPLIAKILL---GFGGNASRSSLPLLSDILGKLKAQVSNEIKRRFLTDL---------------LKARIKDKVKQFWILC............ 975
21 -9.680[K] KOG3779 Homeobox transcription factor prospero  ali follow..  15  585.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................LKKAKLMFFYTR----SSNMLKTYFSDVKFNRCITSQLIKWF-SNFR---EFYYIQ--MEKYARQAINDG---VTSTEELSI--YRALNMHYNKANDEVPERITLREFFN---AIIAGKDVDPSWKKAIYKVICKLDSEVPE............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 723
22 -9.590[Z] COG5022 Myosin heavy chain  ali follow..  12  84.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................LNEPSVLDALSTRYNQ--SGIVLIAVNPFQRLPNLYTHEIVRA-DPAEDSYKCMNQEHKNQTIIGE--GAGKTVSARYIMRYFASVQ-QLTAVENEINPIMEAF---GNSKTSSRF--KYIQILFDGNATIIGAKIQTYLLERSRLVFQPNYHSSEQLEKWKLVEYLKQGNGVNDKEEIDNDTCECIFSLLAA--LHIGNIEVKHSRNDAYIDSKNENLINATSLLGVDPSSLVKWLTKRKIKMASEGILKPLNEFQAVVARDS----------VAKFLYASLFDWLVATINKALMYSADKSNQTA-IYGFE-------HFKKN-----------SFEQFCINYANEKLQQEFYRHVFKLEQEEYAAEGLNWSYILGILSLLDEECRMPTNSDENWVSKLNDAFSKPEFKNSYQKSRFGNKEFTIKHYALDVVYCAEGFIDKNR-----------DTISDELLELFTNSDVPFVKDLVLFRLEQTAPPADTKKIK-------------TKPKSNTLGSMFKSSLVSLMSTINETNAHYI............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ 662
23 -9.550[T] COG5422 RhoGEF, Guanine nucleotide exchange factor for Rho/Rac/Cdc42-like GTPases  ali follow..  291.PPPGLSSMDSNGSSIENNFLYTKRRANTSDSFDSVLSDSSTTPTISSSVQVNSLAFITSSLSAITKEPEAPETEYNPHGVFTLLTECYSSTCSRNRLCYSISCPRRLEQQARLHLKVQPVLSGGSTSITDKQEEDHRLWSENVPKQVVDQIDVREWKRQEIIFEVIYTERDFVRDLEYIR-DFWIKPLSVIPENNRQQFIRCVFHNIMQIHAVN--SRLSNALNRTQTLQPVVNTIGDLFLDPFIKYGANQAIAKFEFEREKS-----------TNRNFANYVHEV---------ERLRESRKLELNGYLTKPTTRLARYP--------------------------------------------------------------------LLLSGVLK------TDKDNPDTENIPR-----VIEMIREFLTKLNYETGKTENRLS----------LLQLNEQL----CSPADRAKLTLFDPSRLLIFKVKLKASSYSNNDIHMFLLDNFLLLCKIKIQMKRRVH-------KLHLRP------------------------LELLSISYIEDSPSRGSLPRRPSSALLTNPISITKSNPPPVKAYGLQLVFIGARGFSISLYLNTLIARDQWKQHIEKQQDIIRKRHLVFESRGICCQSWFTGNKLLCAVAYDAGRSSRKSNNGSCLEPIFKLQLPNISQLDVIEEHNVLLLLAEKILYELP---LDALDSVEQINSKSLRRVTGFVKTGFCMQRILV--AVKSTVNTTLRIYEADRALKNKKPFGNQATLKIF-TEVQMPMEALSVHDIISRFLEKREDIRPIAMFRLRGEFLLCYSDFAFFVNTNGWKSRQSWMINDFIE-IRNAETAE------LVQI---IMGQNIKLLTDGRGLISEGG..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 1124
24 -9.000[LA] KOG2044 5`-3` exonuclease HKE1/RAT1  ali follow..  12  87...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DHLFTLVRPRKILYLAID--GVAPRAKMNQQRSRRFRAAKDAAEAEA--EKAETCDSNVIGPFMAILSVA----LQYYIQS-RLNHNPGWRYVKVILSDSNVPGEGE--HKIMSYI--RLQRNLPGFDPNTHCLYGLDADLIMLSLATHEVHLREVITLREYLQYERIIDDGNDF--NLLMHVYRKEDSGEVLLDAVNEDKIFQKRTRIKQSMDNNEEMKQRSRRDPSEVPPEPIDDKIKLGEPGYKERYYAEKFSTTNPEETEQIKQDMVLKYVEGLCWAPFASDLK--LPDLEITFFIGEPFKPFDQLMGTASSNALPGEYRKLMTD--PSSPILKFYPADFE-----------LDMNGK--RFAWQGIA-KLPFIEEKLLLAA................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 590

FFAS is supported by the NIH grant R01-GM087218-01
1 4 8 3 2 2   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Li Z, Ye Y, Godzik A. Flexible Structural Neighborhood--a database of protein structural similarities and alignments. Nucleic Acids Res. 2006 Jan 1;34(Database issue):D277-80.